Other

Restructuring Reserve Settled Without Cash2

Analysis

StatementCash Flow Statement
SectionOther
CategoryEfficiency
SignalContext dependent
VolatilityModerate

How to read this metric

An increase suggests the company is accounting for future restructuring costs without immediate cash impact, potentially signaling efficiency initiatives.

Detailed definition

This metric captures the portion of restructuring expenses that were recognized in the income statement but did not resu...

Peer comparison

Varies significantly based on the company's current phase of operational transformation or cost-cutting programs.

Metric ID: other_restructuring_reserve_settled_without_cash2

Business Segments

View all
SegmentQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Medical-Surgical Solutions$0.00$0.00$6.00M$8.00M$0.00$0.00$11.00M-$19.00M
Prescription Technology Solutions$1.00M$1.00M$0.00$7.00M$0.00$0.00$0.00$17.00M
North American Pharmaceutical$14.50M-$3.00M$14.00M
International$1.00M$0.00
U.S. Pharmaceutical$1.00M$63.00M$1.00M$0.00
Total

Oncology & Multispecialty is derived from annual filings.

International, U.S. Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.

Frequently Asked Questions

What does restructuring reserve settled without cash2 mean?
Non-cash accounting adjustments related to restructuring reserves that do not involve immediate cash payments.